815 related articles for article (PubMed ID: 19016706)
41. Monochromatic excimer light versus combination of topical steroid with vitamin D3 analogue in the treatment of nonsegmental vitiligo: a randomized blinded comparative study.
Abdel Latif AA; Ibrahim SM
Dermatol Ther; 2015; 28(6):383-9. PubMed ID: 26358764
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
[TBL] [Abstract][Full Text] [Related]
43. Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patients.
Prignano F; Buggiani G; Lotti T
Acta Biomed; 2009 Apr; 80(1):51-6. PubMed ID: 19705621
[TBL] [Abstract][Full Text] [Related]
44. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study.
Nordal EJ; Guleng GE; Rönnevig JR
J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1440-3. PubMed ID: 21466589
[TBL] [Abstract][Full Text] [Related]
45. [Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion].
Ruzicka T; Trompke C
Hautarzt; 2004 Feb; 55(2):165-70. PubMed ID: 14968327
[TBL] [Abstract][Full Text] [Related]
46. Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: a randomized, controlled study.
Klahan S; Asawanonda P
Clin Exp Dermatol; 2009 Dec; 34(8):e1029-30. PubMed ID: 20055831
[No Abstract] [Full Text] [Related]
47. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.
Coskun B; Saral Y; Turgut D
Eur J Dermatol; 2005; 15(2):88-91. PubMed ID: 15757818
[TBL] [Abstract][Full Text] [Related]
48. Clinical efficacy of a novel topical formulation for vitiligo: compared evaluation of different treatment modalities in 149 patients.
Buggiani G; Tsampau D; Hercogovà J; Rossi R; Brazzini B; Lotti T
Dermatol Ther; 2012; 25(5):472-6. PubMed ID: 23046028
[TBL] [Abstract][Full Text] [Related]
49. Topical tacrolimus for treatment of childhood vitiligo in Asians.
Kanwar AJ; Dogra S; Parsad D
Clin Exp Dermatol; 2004 Nov; 29(6):589-92. PubMed ID: 15550128
[TBL] [Abstract][Full Text] [Related]
50. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
[TBL] [Abstract][Full Text] [Related]
51. [Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo].
Rojas-Urdaneta JE; Poleo-Romero AG
Invest Clin; 2007 Mar; 48(1):21-31. PubMed ID: 17432541
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo.
Kapoor R; Phiske MM; Jerajani HR
Br J Dermatol; 2009 Apr; 160(4):861-3. PubMed ID: 19014395
[TBL] [Abstract][Full Text] [Related]
53. Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus.
Taher ZA; Lauzon G; Maguiness S; Dytoc MT
Br J Dermatol; 2009 Sep; 161(3):654-9. PubMed ID: 19438859
[TBL] [Abstract][Full Text] [Related]
54. No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo.
Ada S; Sahin S; Boztepe G; Karaduman A; Kölemen F
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):79-83. PubMed ID: 15752125
[TBL] [Abstract][Full Text] [Related]
55. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
Westerhof W; Nieuweboer-Krobotova L
Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
[TBL] [Abstract][Full Text] [Related]
56. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo.
Goktas EO; Aydin F; Senturk N; Canturk MT; Turanli AY
J Eur Acad Dermatol Venereol; 2006 May; 20(5):553-7. PubMed ID: 16684283
[TBL] [Abstract][Full Text] [Related]
57. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment.
Sánchez Regaña M; Márquez Balbás G; Umbert Millet P
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337
[TBL] [Abstract][Full Text] [Related]
58. In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model.
Faas L; Venkatasamy R; Hider RC; Young AR; Soumyanath A
Br J Dermatol; 2008 May; 158(5):941-50. PubMed ID: 18284389
[TBL] [Abstract][Full Text] [Related]
59. High-concentration (20 mug/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids.
Katayama I; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S
Eur J Dermatol; 2002; 12(6):553-7. PubMed ID: 12459526
[TBL] [Abstract][Full Text] [Related]
60. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines.
Grimes PE; Morris R; Avaniss-Aghajani E; Soriano T; Meraz M; Metzger A
J Am Acad Dermatol; 2004 Jul; 51(1):52-61. PubMed ID: 15243524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
